Free public records show CSPC Megalith Biopharmaceutical Co.,Ltd. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by CSPC Megalith Biopharmaceutical Co.,Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
42 active studies led by CSPC Megalith Biopharmaceutical Co.,Ltd., of 42 in all
Source: ClinicalTrials.gov, Studies with CSPC Megalith Biopharmaceutical Co.,Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies CSPC Megalith Biopharmaceutical Co.,Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with CSPC Megalith Biopharmaceutical Co.,Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show CSPC Megalith Biopharmaceutical Co.,Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets CSPC Megalith Biopharmaceutical Co.,Ltd. is in.
Stories on the topics CSPC Megalith Biopharmaceutical Co.,Ltd. works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
ReadSearch all reports for CSPC Megalith Biopharmaceutical Co.,Ltd. All companies